Synnovia (LON:SYN) has released its full-year (FY) results to March 2019. These were in line with the forecasts we issued following the April 2019 trading statement. Revenues increased 8.7% to £81.6mln, earnings before interest, tax, depreciation, and amortisation (EBITDA) were up 7.3% at £7.5mln,
FY19A results confirm another record year for revenues (£81.6m, +9%) and adj EBITDA (£7.6m, +7%), reflecting returns on prior capital investment. Synnovia has now resolved disruption from the installation of new Films capacity over Q4/19 and we see potential for margin appreciation across the group in FY20E. However, today's cautious outlook statement warns of relatively weak trading over Q1/20E following evidence of pre-Brexit stockpiling. Despite this, we still expect the current organic momentum to continue given new business wins, with a 5% uplift in EPS in FY20E.
Synnnovia PLC (LON:SYN) has released a trading update for the year to 31 March. The company continues to expect significant growth in revenue and profits, with progress remaining strong in the higher margin Industrial division. However, profitability for the group as a whole will now be below previo
Synnovia has provided a further trading update at FY19A's close, confirming the effect of previously highlighted capacity constraints in the Films division have not been fully overcome, leading to FY19A results being “marginally below” our previous expectations (revenues £83.1m, adj EBITDA £7.8m, adj EPS 10.3p p/s). While this event, along with additional costs associated with Synnovia's continuing investment programme, will now hinder meaningful EPS growth this year, we consider the former to be a temporary operational issue which is set to be resolved early into FY20E. Despite this, Synnovia is still set to deliver strong, organic YoY revenue growth (+9%) and profit/EPS improvement (albeit more modestly) this year.
Synnovia plc (formerly Plastics Capital plc) issued a trading update today indicating that although trading has been strong across the Group, capacity increases in the Films Division were delayed beyond expectations. These delays, coupled with associated increased costs and unexpected cost inflation, have impacted profitability in Films. As a result, Group profits are expected to be marginally below current market expectations but still ahead of the previous year. Trading in the higher margin Industrial Division has remained strong, especially in the bearings business. To reflect the reduced profitability within the Films Division we are reducing Group EPS forecasts by c.9% to 9.7p for the year to March 2019 and c.10% to 11.5p for FY2019/20. (Ian Jermin)
Synnovia (LON:SYN) released a trading update on 19 February, confirming that trading in the full year (FY) to 31 March is broadly in line with expectations. We continue to forecast growth in revenue and earnings; however, we are lowering our FY earnings per share (EPS) forecast from 11.9p to 10.4p
Synnovia has provided a trading update today, stating that it expects FY19E results to be “broadly in-line” with market expectations. The slight shortfall versus our previous forecasts (£83.8m in revenue, £8.3m of adj EBITDA) comes as the Films division recently suffered delays in the installation of new capacity leading to temporary constraints in the face of strong demand, while the operationally geared Industrials division has made further YoY progress since the interim results. We consider the shortfall to be a temporary in nature and see Films' need to add capacity as a positive indicator of growth prospects into FY20E and beyond.
Synnovia plc (formerly Plastics Capital plc) issued a trading update today indicating that although trading was strong across the Group, capacity and capability increases in the Films Division have been delayed. Relative to expectations, volumes and margins are down as higher margin products have been the ones constrained by capacity. Meanwhile costs were increased during the year to meet the additional volumes which have not fully come through. Although the Group expects full year results to March 2019 to be broadly in line with market expectations, we believe it prudent to pull back our EBITDA forecast by around 15% from £8.6m to £8.0m and adjusted EPS from 11.9p to 10.7p. (Ian Jermin)
Plastic's interim results continue the narrative from FY18A of strong organic growth as a result of continued investment in the business. However, this year, given a rebound in the operationally geared Industrials division (in particular in bearings) and an unwind of FX hedges, material profit growth has also been witnessed. This result provides a solid start to achieving FY19E forecasts. Given current progress, the Board has revised its long-term organic EBITDA target to £15m+ by FY23/24E.
Plastics Capital plc (shortly to be renamed Synnovia plc) reported excellent results for the half year to September 2018. Strong organic growth in the operationally geared bearings business, continued progress in the creasing matrix activities and another period of encouraging growth in films, led to revenue growth for the Group of 12.1%. Investment in all business streams utilised the cash generated in the half year as well as additional borrowings, resulting in a modest increase in net debt from £15m to £15.7m. The Group also benefitted from the depreciation of sterling post the Brexit referendum leading, in part, to an increase in adjusted EBITDA of 42.8%. Trading in H2 has started well and we believe that the group is on track to meet our full-year earnings expectations and therefore we retain our fair value of 130p.
Plastics Capital (LON:PLA) has reported first half (H1) results to September 2018 showing revenue growth of +11.4%, underlying earnings (EBITDA) growth of +42.8%, and adjusted earnings per share (EPS) growth of +67.9%. These results reinforce our confidence in our full-year (FY) March 2019 forecasts, including our EPS growth forecast of 25.3%.
Plastics has provided a positive trading update confirming FY18A's double-digit organic revenue growth has continued through H1/19E. Group profit has also improved, as the operationally geared Industrials division recovers after a disappointing FY18A. Trading to date is in-line with FY19E forecasts, a year in which we expect 21% growth in adj EPS. Despite this, the shares trade on a P/E of 9.6x and we expect this to appreciate with continued evidence of a successful FY19E delivery.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Synnovia.
We currently have 57 research reports from 5
COVID-19 update – continuing to operate, div. suspended
Companies: Scapa Group
Companies: AVO AGY ARBB ARIX BUR CMH CLIG DNL GDR HAYD PCA PIN PHP RE/ RECI RMDL STX SHED VTA
Treatt demonstrated its strength and resilience in H120, as so far the COVID-19 pandemic has not had any adverse impact on trading performance. Of course, this is in part due to the categories in which Treatt operates, with some of its products being used in household cleaners, which have witnessed a global spike in demand. Nevertheless, the steady performance is testament to the management and culture of the business, which have been able to withstand the unexpected and exogenous shock. H219 and H120 were affected by a global weakness in citrus raw material prices, which in turn affected revenue growth. Citrus prices have now started to firm and we expect growth in this category to return in H2. We leave our forecasts mostly unchanged but roll forward our DCF and hence our fair value rises to 560p (from 530p previously).
There has been much comment on the fact that equity markets in the US and Europe have been shrinking for some years now, certainly in terms of the number of quoted companies, if not in total market capitalisation (MCap). This paper has been written with the assistance of the Quoted Companies Alliance (QCA) and focuses on the evidence for such in the London market and, in particular, that for smaller and midcap companies. It assesses that evidence and considers explanations. Finally, we ask why it matters, and assuming that it does, what practical steps can be taken to reverse the trend. Successful public markets have been a key part of the United Kingdom’s economic success for generations, even centuries, and we should not allow them to wither on the vine.
Companies: AVO AGY ARBB ARIX ASAI DNL GDR HAYD NSF PCA PIN PXC PHP RE/ RECI RMDL STX SCE TRX TON SHED VTA
Covestro’s management gave some further insights on Q2 developments during its virtual sellside round table. Having gone 2/3rds through the second quarter, management indicated some recovery was to be seen in its core volumes in June having looked into the order book.
Management’s recovery scenario is based on getting back to the pre-crisis GDP level in 2023, which is rather more moderate than our picture but does not force us to take immediate action.
When is a bubble not a bubble but a fundamental and lasting shift in investor sentiment towards a sector? Despite repeated calls from the biotech bear camp that the end is in sight for the continued optimism enjoyed by the sector we continue to enjoy a burst of IPOs, fundraisings and M&A deals.
Companies: EDEN MTFB TILS SDI GDR IMM BMK AVO AVCT
Airbus secures €15bn credit facility but partially restarts production in France & Spain, Cummins suspends production and FY20 guidance as customers shutdown
Companies: CGS HAYD HEAD HTG OXIG RSW RNO ROR TWD TRI ZTF GHH
US & German manufacturing PMI hits lowest readings since 2009, UK manufacturing PMI heads below 50, BorgWarner expects material financial impact from customer production halts
Companies: AVON CGS HAYD HEAD HILS JHD RNO SCPA TWD TRI ZTF SOM GHH
2019 Results – Likely Investor concern over debt
Against a backdrop of generally negative company announcements, Hardide bucked the trend by releasing solid interim results for the 6 months ended March 2020, noting limited impact to date from COVID-19 and a positive trading outlook. Furthermore, the allimportant move to new facilities and corresponding capacity expansion is both on track and on budget. Several of Hardide’s end markets will clearly be feeling the impact of COVID-19. However, we feel the importance of Hardide’s technology to its customers by extending the useful life of components and its diversity of end markets across multiple sectors including oil & gas, aerospace, flow control, power generation and precision engineering is enabling it to weather the storm. We leave our forecasts unchanged and see potential for an upgrade should end markets maintain strength and H2 margins match those of H1.